VIRUN and Vital Pharmaceuticals Expand Operations
VIRUN and Vital Pharmaceuticals expand vertically-integrated solutions for finished product applications containing OmegaH2O® Omega-3 EPA DHA, PQQwater™ Coenzyme Clear® and other patented/patents-pending products and technologies.
- Miami, FL (1888PressRelease) November 27, 2013 - VIRUN headquarters in Walnut, Calif., has reached capacity and therefore, has successfully expanded its production operations to Weston, Fla., as an effort to support the growing demand of FUXIONS™ ingredients through the Specialty Products Division at Hormel Foods. The new facility is a state-of-the-art cGMP facility that can produce up to 20,000 gallons a day. Utilizing VIRUN's vast patent and patents pending portfolio, this new facility will allow extended efficiency in processing, higher yield production and will also facilitate VIRUN's patent-pending HCO3 extraction process.
What is unique about this expansion is that VIRUN's new facility will be adjacent with Vital Pharmaceuticals. This integration will allow a 2-step process from raw material manufacturing into finished product application. Nicole Shute, marketing manager-Specialty Products at Hormel Foods stated "There is growing interest for FUXIONS™ ingredients, in particular with supplement beverage applications that demand differentiation in the market place. This expansion and partnership will assist FUXIONS™ application development with finished product actualization."
Vital Pharmaceuticals, a 20 year nutrition and beverage industry leader that is largely based on founder and CEO Jack Owoc's ability to develop and scale conceptualized ideas into actual finished products in-house. Their 200,000 square foot facility produces liquid shots, multi-serving liquid products, including proprietary 3 ounce, 8 ounce, 16 ounce and 20 ounce beverages all on their multiple rotary or piston filling lines. Vital Pharmaceuticals (VPX) has also developed in-house proprietary encapsulation technologies that enable an immediate yet sustainable tri-phase pharmacokinetic delivery. VPX has funded 22 double blind placebo-controlled human studies on its products to drive proven innovations. Perhaps what is truly spectacular is that Vital Pharmaceuticals has recently developed their own in-house nutrition bar manufacturing to allow excellent source Omega-3 EPA and DHA claims in a single serving, whole food bar.
The partnership will allow customers to produce the raw material Omega-3 EPA DHA or other water insoluble component and manufacture their finished food, liquid capsules, powders emulsion concentrates and beverages all in one cGMP biotech and food processing block in Weston, Fla. Key advantages of these products will be: all-natural, no preservatives (such as potassium sorbate or EDTA), no undeclared additives and only GRAS, clean label ingredients for direct food use (no polysorbates or hydrogenated castor oil PEG 40).
Mr. Owoc stated,"VIRUN's integration with Vital Pharmaceuticals just makes sense from many different perspectives - I nicknamed Bromley, 'Phil the Thrill' for a reason; together we have an innovation wheel that is going to produce dozens of $100 million+ beverages, supplements and nutrition products. 'More importantly, the big picture Vital/Virun vision is uniquely aligned to produce finished inventions backed by a scientific explosion of innovation in order to improve the health and quality of life of billions of individuals." Philip Bromley, CEO of VIRUN agrees with Sports Illustrated who refers to CEO Owoc as the 'Willy Wonka' of supplement industry; "Having this opportunity to work with them is humbling and VIRUN is fortunate to be a part of this great organization" Mr. Bromley stated.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam